SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-100009
Filing Date
2023-12-29
Accepted
2023-12-29 17:00:43
Documents
5
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1223_abvcbio.htm DEF 14A 9977041
2 GRAPHIC tflowchart_001.jpg GRAPHIC 342637
3 GRAPHIC twwc_header.jpg GRAPHIC 113423
4 GRAPHIC twwc_sign.jpg GRAPHIC 11546
5 GRAPHIC twwc_footer.jpg GRAPHIC 76830
  Complete submission text file 0001213900-23-100009.txt   10728762
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40700 | Film No.: 231528415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)